Drugs / 89Zr-CD147
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT04841421 | May 2021 → Mar 2023 | cancer | Sinotau Pharmaceutical Group | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 89Zr-CD147 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04841421 ↗ |
| Modality | Diagnostic / imaging agent | “positron emission tomography probe” NCT04841421 ↗ |